Gabapentin
Product Images NDC 42254-112

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 42254-112). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rebel Distributors Corp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Dc2d0eb8-figure-01 (3345e995 7c5a 4e1c 949a 396ca7332023 01)

Chemical structure diagram of Gabapentin, showing its molecular arrangement with a cyclohexane ring attached to an aminomethyl and a carboxymethyl group.*

FDA Label Image

Dc2d0eb8-figure-02 (3345e995 7c5a 4e1c 949a 396ca7332023 02)

Line graph depicting mean pain score over an 8-week period comparing placebo and Gabapentin 3600 mg/day. The x-axis represents weeks, including a 4-week dose titration period and a 4-week fixed dose period. Gabapentin shows a decreasing mean pain score trend compared to stable scores for placebo, with statistical significance indicated by asterisks (p < 0.01).*

FDA Label Image

Dc2d0eb8-figure-03 (3345e995 7c5a 4e1c 949a 396ca7332023 03)

A line graph displaying mean pain scores over 8 weeks comparing placebo and Gabapentin 3600 mg/day. The x-axis shows weeks with a 4-week dose titration period followed by a 4-week fixed dose period. The y-axis indicates mean pain scores from 0 to 10. Gabapentin's line shows a decline in pain scores over time, while placebo remains relatively stable.*

FDA Label Image

Dc2d0eb8-figure-04 (3345e995 7c5a 4e1c 949a 396ca7332023 04)

A bar chart comparing the percentage of responders at endpoint in two studies of Gabapentin (GBP) versus placebo (PBO). Study 1 shows GBP 3600 mg with 29% responders compared to 12% for placebo. Study 2 shows GBP 1800 mg with 32% responders, GBP 2400 mg with 34%, and placebo with 14%, with significance levels indicated for GBP groups.*

FDA Label Image

Dc2d0eb8-figure-05 (3345e995 7c5a 4e1c 949a 396ca7332023 05)

A scatter plot depicting the percent difference on the y-axis against daily dose in milligrams on the x-axis for Gabapentin across three studies labeled as study a, study b, and study c. Data points show increasing differences with higher doses, ranging from approximately 600 mg to 1800 mg daily dose.*

FDA Label Image

Gabapentin 100mg (3345e995 7c5a 4e1c 949a 396ca7332023 06)

Gabapentin 100mg capsules label from Physician Partner, a division of Rebel Distributors Corp. The label states each capsule contains 100mg of Gabapentin and the package contains 90 capsules. It includes storage instructions to keep at 15-30°C and warnings to keep medication out of children's reach. Manufacturer listed as Amneal Pharmaceuticals of NY.*

FDA Label Image

Gabapentin 400mg (3345e995 7c5a 4e1c 949a 396ca7332023 07)

Gabapentin 400mg capsules label with a quantity of 60 capsules. The capsules contain 400mg of Gabapentin each and are described as light caramel-colored, opaque hard gelatin capsules printed with "IP 103" on both cap and body. Labeled by Physician Partner, a division of Rebel Distributors Corp. The label includes storage instructions and manufacturer details for Amneal Pharmaceuticals of NY Hauppauge, NY.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.